Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Perindopril erbumine 3mg/5ml oral solution
0205051M0AAAMAM
|
Perindopril erbumine | Perindopril erbumine | Cardiovascular System | No data available |
|
Perindopril tosilate 10mg tablets
0205051AAAAACAC
|
Perindopril tosilate | Perindopril tosilate | Cardiovascular System | No data available |
|
Perindopril tosilate 2.5mg tablets
0205051AAAAAAAA
|
Perindopril tosilate | Perindopril tosilate | Cardiovascular System | No data available |
|
Perindopril tosilate 5mg / Indapamide 1.25mg tablets
0205051ABAAAAAA
|
Perindopril tosilate/indapamide | Perindopril tosilate/indapamide | Cardiovascular System | No data available |
|
Perindopril tosilate 5mg tablets
0205051AAAAABAB
|
Perindopril tosilate | Perindopril tosilate | Cardiovascular System | No data available |
|
Persantin 100mg tablets
0209000L0BBABAC
|
Persantin | Dipyridamole | Cardiovascular System | No data available |
|
Persantin 10mg/2ml solution for injection ampoules
0209000L0BBACAA
|
Persantin | Dipyridamole | Cardiovascular System | No data available |
|
Persantin 25mg tablets
0209000L0BBAAAB
|
Persantin | Dipyridamole | Cardiovascular System | No data available |
|
Persantin Retard 200mg capsules (Boehringer Ingelheim)
0209000L0BBAFAM
|
Persantin | Dipyridamole | Cardiovascular System | No data available |
|
Phasonit LA50 capsules
0206010K0CQABAF
|
Phasonit | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Phenindione 50mg tablets
0208020N0AAACAC
|
Phenindione | Phenindione | Cardiovascular System | No data available |
|
Phenoxybenzamine 100mg/2ml solution for infusion ampoules
0205040M0AAADAD
|
Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride | Cardiovascular System | No data available |
|
Phenoxybenzamine 10mg/5ml oral liquid
0205040M0AAANAN
|
Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride | Cardiovascular System | No data available |
|
Phenoxybenzamine 25mg/5ml oral liquid
0205040M0AAAMAM
|
Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride | Cardiovascular System | No data available |
|
Phenoxybenzamine 5mg/5ml oral liquid
0205040M0AAAPAP
|
Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride | Cardiovascular System | No data available |
|
Phenprocoumon 3mg tablets
0208020S0AAAAAA
|
Phenprocoumon | Phenprocoumon | Cardiovascular System | No data available |
|
Phentolamine 10mg/1ml solution for injection ampoules
0205040P0AAAAAA
|
Phentolam mesilate | Phentolamine mesilate | Cardiovascular System | No data available |
|
Phenylephrine 50mg capsules
0207020X0AAACAC
|
Phenylephrine hydrochloride (Systemic) | Phenylephrine hydrochloride | Cardiovascular System | No data available |
|
Physiotens 200microgram tablets (Actavis)
0205020M0BBADAA
|
Physiotens | Moxonidine | Cardiovascular System | No data available |
|
Physiotens 300microgram tablets (Actavis)
0205020M0BBAFAC
|
Physiotens | Moxonidine | Cardiovascular System | No data available |
|
Physiotens 400microgram tablets (Actavis)
0205020M0BBAEAB
|
Physiotens | Moxonidine | Cardiovascular System | No data available |
|
Pindolol 10mg / Clopamide 5mg tablets
020400010AAAAAA
|
Pindolol/clopamide | Pindolol with diuretic | Cardiovascular System | No data available |
|
Pindolol 15mg tablets
0204000P0AAABAB
|
Pindolol | Pindolol | Cardiovascular System | No data available |
|
Pinmactil 80mg modified-release tablets
0212000M0BDAAAD
|
Pinmactil | Fluvastatin sodium | Cardiovascular System | No data available |
|
Plavix 300mg tablets
0209000C0BBABAE
|
Plavix | Clopidogrel | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.